Evaluation of a Transfusion Therapy Using Whole Blood in the Management of Coagulopathy in Patients With Acute Traumatic Hemorrhage
Conditions:   Trauma;   Acute Hemorrhage;   Coagulopathy Interventions:   Drug: Whole blood transfusion;   Drug: Fractionated blood products transfusion Sponsors:   Direction Centrale du Service de Santé des Armées;   TIMC-IMAG;   Floralis Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2020 Category: Research Source Type: clinical trials

Perioperative Pediatric Blood Transfusion Therapy
Condition:   Transfusion Intervention:   Sponsor:   Johann Wolfgang Goethe University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2020 Category: Research Source Type: clinical trials

Comparison of Lower-risk MDS Patients With and Without Improvements in Fatigue Following Blood Transfusion Therapy
Condition:   Myelodysplatic Syndromes Intervention:   Other: Physiological tests to measure fatigue level Sponsors:   Institut de Cancérologie de la Loire;   Laboratoire Interuniversitaire de Biologie de la Motricité - Jean Monnet University Saint-Etienne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2019 Category: Research Source Type: clinical trials

iTACTIC – implementing Treatment Algorithms for the Correction of Trauma-Induced Coagulopathy: study protocol for a multicentre, randomised controlled trial
DiscussionCCTs have traditionally been used to detect TIC and monitor response to treatment in traumatic major haemorrhage. The use of VHAs is increasing, but limited evidence exists to support the superiority of these technologies (or comparatively) for patient-centred outcomes. This knowledge gap will be addressed by this trial.Trial registrationClinicalTrials.gov, ID:NCT02593877. Registered on 15 October 2015.Trial sponsorQueen Mary University of LondonThe contact person of the above sponsor organisation is: Dr. Sally Burtles, Director of Research Services and Business Development, Joint Research Management Office, QM I...
Source: Trials - October 18, 2017 Category: Research Source Type: clinical trials

Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia
Conditions:   Acute Biphenotypic Leukemia;   Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   B-Cell Non-Hodgkin Lymphoma;   Chronic Lymphocytic Leukemia;   Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Hematologic and Lymphocytic Disorder;   Hematopoietic Cell Transpla ntation Recipient;   Myelodysplastic Syndrome;   Primary Myelofibrosis;   Secondary Myelofibrosis;   T-Cell Non-Hodgkin Lymphoma;   Thrombocytopenia;  ...
Source: ClinicalTrials.gov - June 13, 2017 Category: Research Source Type: clinical trials